Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Byam Rebecca, Chief Financial Officer. Director active across 1 company, notably HCW Biologics Inc.. Cumulatively, 25 disclosures have been logged. Split: 21 buys · 0 sell. Total volume traded: €969k. History available since 22 July 2021. The latest transaction was filed on 22 May 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Byam Rebecca
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25,000 shares@ US$8.008.8% of flowCommon StockSEC:0001209191-21-048079:0
Canonical exit: 20 Oct 2021 (T+90)
25 of 25 declarations
About Byam Rebecca
Byam Rebecca is Director Financial at HCW Biologics Inc. She has filed 25 forms in total, and across the recent filings tracked between 2021-07-23 and 2026-05-27, the transactions are predominantly acquisitions, with EUR 968822 of buys and EUR 0 of sells.